LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹5.29 Cr | ₹1.95 Cr | ₹-22 Cr | ₹-63 Cr | ₹-12 Cr |
What is the latest Cash Flow from Financing Activities ratio of LYKA LABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹5.29 Cr |
| Mar2024 | ₹1.95 Cr |
| Mar2023 | ₹-22 Cr |
| Mar2022 | ₹-63 Cr |
| Mar2021 | ₹-12 Cr |
How is Cash Flow from Financing Activities of LYKA LABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.29 Cr | 170.97 | |
| Mar2024 | ₹1.95 Cr | Positive | |
| Mar2023 | ₹-22 Cr | Negative | |
| Mar2022 | ₹-63 Cr | Negative | |
| Mar2021 | ₹-12 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹263.2 Cr | -2% | 14.1% | -39.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -2% |
14.1% |
-39.3% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses